$BIO recent market performance has been rather lackluster. In the current cycle of narratives, it has temporarily slipped out of the mainstream view. At the DeSci Berlin Conference, the release of the OpenLabs platform brought only sporadic community mentions, without triggering any notable increase in trading volume or media attention. When the community’s focus is entirely captured by popular biotech and AI projects, projects that lack fresh narratives naturally face selling pressure.
That said, looking from another angle: a 24-hour trading volume of 33.18 million, a market cap of 64.11 million, and a price of $0.0289 are actually not too bad given the current market environment. The DeSci track’s narrative hasn’t fully taken off yet—maybe this quiet period is a good time to set up a position?
#DeSci #BioProtocol
That said, looking from another angle: a 24-hour trading volume of 33.18 million, a market cap of 64.11 million, and a price of $0.0289 are actually not too bad given the current market environment. The DeSci track’s narrative hasn’t fully taken off yet—maybe this quiet period is a good time to set up a position?
#DeSci #BioProtocol